A combination of IP, corporate transactional, litigation and finance knowledge and focus, coupled with innovative strategies for reaching client goals along the way, are what clients can expect from Barnes & Thornburg’s Life Sciences group.
We partner with entities engaged in biotechnology, pharmaceuticals, medical and laboratory devices, healthcare and bioinformatics to advance key discoveries to the marketplace. Our attorneys work with clients on trademark analysis, pharmaceutical patent prosecution, patent portfolio management, Hatch-Waxman litigation, and pharmaceutical and biological client counseling.
In this exciting and growing tech climate, biotech companies, universities, hospitals, and technology centers in the initial stages of research and development rely on our attorneys and patent agents with backgrounds in chemistry, molecular biology, engineering and genetics to assist with commercializing their IP assets. Our transactional attorneys have experience advising clients on the proper business entity selection and preparing documents related to entity creation and regulatory compliance. Our IP attorneys have significant experience in licensing agreements to assist moving innovations into the marketplace.
In addition, we help enterprises work through government, regulatory and tax issues related to their technology and products, as well as help with recruiting and retaining qualified employees.
A number of our lawyers have been in-house counsel to large multinational firms. In addition, many of our patent lawyers and agents hold Ph.D.s and we have deep experience in biotech, pharmaceutical and medical device technologies, including:
- Gene therapy
- Combinatorial chemistry
- Transgenic technology
- Plant genetics
- Pharmaceuticals and drug discovery
- Medical imaging and display
- Molecular biology